InMed Pharmaceuticals Inc. (INM)
NASDAQ · Healthcare
InMed Pharmaceuticals Inc. EPS 2021–2025
InMed Pharmaceuticals Inc. annual/quarterly eps history and growth rate from 2021 to 2025. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- InMed Pharmaceuticals Inc. eps for the quarter ending December 31, 2025 was $0.51, a 85.99% decrease year-over-year.
- InMed Pharmaceuticals Inc. annual eps for 2025 was $8.36, a 58.49% decrease from 2024.
- InMed Pharmaceuticals Inc. annual eps for 2024 was $20.14, a 519.69% increase from 2023.
- InMed Pharmaceuticals Inc. annual eps for 2023 was $3.25, a 90.20% decrease from 2022.
- InMed Pharmaceuticals Inc. annual eps for 2022 was $33.17.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
InMed Pharmaceuticals Inc. EPS — FAQ
InMed Pharmaceuticals Inc. (INM) eps over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is InMed Pharmaceuticals Inc.'s eps?
InMed Pharmaceuticals Inc. (INM) reported eps of $-8.36 for fiscal 2025.
Where can I see INM's eps history?
The chart and table above show InMed Pharmaceuticals Inc.'s eps by year and by quarter, including the growth rate.